https://pharminent.com/biogen-data-highlight-promise-questions-surrounding-tau-targeting-alzheimers-drugs/ 2026-07-14T15:11:05Z Pharminent en Biogen data highlight promise, questions surrounding tau-targeting Alzheimer's drugs 2026-07-14T13:15:00Z Blog https://pharminent.com/novartis-and-chai-discovery-collaborate-on-antibody-identification-2/ 2026-07-14T15:12:25Z Pharminent en Novartis and Chai Discovery collaborate on antibody identification 2026-07-14T08:57:47Z Blog https://pharminent.com/mahzi-lets-rare-disease-families-invest-in-its-gene-therapy/ 2026-07-13T20:40:24Z Pharminent en Mahzi Lets Rare-Disease Families Invest in Its Gene Therapy 2026-07-13T20:40:24Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-july-13-2026/ 2026-07-13T20:27:29Z Pharminent en Rare Disease & Gene Therapy Digest • July 13, 2026 2026-07-13T20:27:27Z Blog https://pharminent.com/fda-posts-14-new-rejection-letters-just-days-after-confirming-a-pause/ 2026-07-13T20:32:11Z Pharminent en FDA Posts 14 New Rejection Letters Just Days After Confirming a Pause 2026-07-13T19:54:21Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-13-2026/ 2026-07-13T16:07:21Z Pharminent en Strategic News Watch • July 13, 2026 2026-07-13T16:07:19Z Blog https://pharminent.com/germany-approves-healthcare-costs-overhaul-despite-significant-pharma-opposition/ 2026-07-14T15:06:10Z Pharminent en Germany approves healthcare costs overhaul despite significant pharma opposition 2026-07-13T15:11:38Z Blog https://pharminent.com/major-trial-launched-to-explore-glp-1-benefit-in-dementia/ 2026-07-14T13:18:13Z Pharminent en Major trial launched to explore GLP-1 benefit in dementia 2026-07-13T13:04:52Z Blog https://pharminent.com/fda-posts-new-rejection-letters-days-after-confirming-pause/ 2026-07-14T13:18:47Z Pharminent en FDA posts new rejection letters days after confirming pause 2026-07-13T11:24:32Z Blog https://pharminent.com/fda-approves-msds-keytruda-combinations-for-mibc-2/ 2026-07-13T14:59:16Z Pharminent en FDA approves MSD's Keytruda combinations for MIBC 2026-07-13T08:31:27Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-july-10-2026/ 2026-07-12T18:29:17Z Pharminent en Oncology Intelligence Digest • July 10, 2026 2026-07-12T18:29:15Z Blog